Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7834919rdf:typepubmed:Citationlld:pubmed
pubmed-article:7834919lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C0005889lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C1521806lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C0005367lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C0019014lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C0205411lld:lifeskim
pubmed-article:7834919lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:7834919pubmed:issue4lld:pubmed
pubmed-article:7834919pubmed:dateCreated1995-2-24lld:pubmed
pubmed-article:7834919pubmed:abstractTextWe investigated the metabolic and hemodynamic effects of a lactate- and a bicarbonate-buffered (bicarbonate concentration 31.4 mmol/l, type I) hemofiltration substitution fluid in a prospective crossover study of 3 weeks each in 11 patients on maintenance hemofiltration. The lactate-buffered hemofiltration (lactate concentration 34-44.5 mmol/l) lead to hyperlactatemia in all patients without signs of overt lactic acidosis but showed a better control of acid-base balance (pH, base excess, standard bicarbonate) than the type I bicarbonate-buffered fluid (p < 0.01). In 6 patients a higher concentration of bicarbonate- (39.7 mmol/l, type II) buffered fluid was tested. The parameters of acid-base balance showed a better control during type II than during type I bicarbonate hemofiltration and were similar to the lactate-buffered phase. Plasma lactate levels between type I and type II bicarbonate hemofiltration were not different. Also in the steady state phase of the treatment (days 7-9 [week 3]) parameters of acid-base balance rose more to normal values during type II than during lactate-buffered hemofiltration. Hemodynamic parameters showed no differences between the three types of buffers used. Furthermore, also the type II bicarbonate fluid was well tolerated. Bicarbonate in a higher concentration (39.7 mmol/l) proved to be a safe and practical alternative to lactate-buffered hemofiltration.lld:pubmed
pubmed-article:7834919pubmed:languageenglld:pubmed
pubmed-article:7834919pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:citationSubsetIMlld:pubmed
pubmed-article:7834919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7834919pubmed:statusMEDLINElld:pubmed
pubmed-article:7834919pubmed:monthOctlld:pubmed
pubmed-article:7834919pubmed:issn0301-0430lld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:SieberthH GHGlld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:BöhmRRlld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:RiehlJJlld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:MannHHlld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:GladziwaUUlld:pubmed
pubmed-article:7834919pubmed:authorpubmed-author:ClasenWWlld:pubmed
pubmed-article:7834919pubmed:issnTypePrintlld:pubmed
pubmed-article:7834919pubmed:volume42lld:pubmed
pubmed-article:7834919pubmed:ownerNLMlld:pubmed
pubmed-article:7834919pubmed:authorsCompleteYlld:pubmed
pubmed-article:7834919pubmed:pagination257-62lld:pubmed
pubmed-article:7834919pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:meshHeadingpubmed-meshheading:7834919-...lld:pubmed
pubmed-article:7834919pubmed:year1994lld:pubmed
pubmed-article:7834919pubmed:articleTitleWhich bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration?lld:pubmed
pubmed-article:7834919pubmed:affiliationII. Medical Clinic, Technical University of Aachen, Germany.lld:pubmed
pubmed-article:7834919pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7834919pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7834919pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7834919pubmed:publicationTypeControlled Clinical Triallld:pubmed